Zenotech Laboratories share news, announcements and annual reports
BSE: 532039Pharmaceuticals & BiotechnologySmall Cap
Zenotech Laboratories Limited · Face value ₹10 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Oct 1996
Last close ₹37.95up ₹0.15 (0.40%)
Share price at the BSE close on 29 Oct 2026. Previous close ₹37.80.
29 Oct: open ₹38.06, high ₹39.20, low ₹36.92
52-week range of traded prices to 29 Oct 2026
₹33.55Low, 30 Mar 2026₹54.14High, 31 Oct 2025
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹232 Cr2,190th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- Lossover the last 12 months
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 2.51
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- −4.5%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- −8.8%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Sep 2026.
- 0.00
- Volume, BSEVolume. Shares traded on the last trading day. Volume in the glossary
- 19,861
Zenotech Laboratories share news and announcements
496 announcements, routine notices left out, newest first. Page 10 of 10.
Dec 2012
6 Dec · Management
6 Dec · Results
Oct 2012
4 Oct · Management
Dr. Jayaram Chigurupati has ceased to be the Managing Director of the Company upon completion of his term on September 30, 2012.
Aug 2012
Jul 2012
Jun 2012
18 Jun · Meeting
Register of Members & Share Transfer Books of the Company will remain closed from July 19, 2012 to July 25, 2012 (both days inclusive) ....
Dec 2011
14 Dec · Management
Board of Directors have vide resolution passed by circulation approved the appointment of Mr. Udbhav Ganjoo as an Additional (Non-executive ....
Sep 2011
6 Sep · Meeting
Registrar of Companies, Andhra Pradesh, Hyderabad has granted extension of time to the Company for holding the Annual General Meeting (AGM) ....
Aug 2011
18 Aug · Management
Board of Directors of the Company has appointed Dr. Sudershan K. Arora, Chairman as Executive Chairman of the Company with effect from ....1 Aug · Change in Registered Office
Registered office of the Company has been shifted within the same city effective from i.e. August 01, 2011. The new address of the Registered ....
Jul 2011
21 Jul · Meeting
Members at the Extra Ordinary General Meeting (EGM) of the Company held on July 21, 2011, have unanimously approved the appointment of ....21 Jul · Board meeting
Board of Directors of the Company at its meeting held on July 21, 2011, have noted the resignation of Justice (Retd.) A. Gopal Rao, an ....
May 2011
19 May · Management
Company has appointed Mr. I Srinivas, an associate member of ICSI, New Delhi as the Company Secretary cum Compliance officer of the company ....
Mar 2011
Feb 2011
14 Feb · Results
Jan 2011
28 Jan · USFDA Approval
Company has received USFDA approval for General Injectables facility located at Turkapally village, Shameerpet Mandal, Hyderabad. ....
Dec 2010
14 Dec · Meeting
Register of Members & Share Transfer Books of the Company will remain closed from January 14, 2011 to January 18, 2011 (both days inclusive) ....11 Dec · Results
Oct 2010
26 Oct · Results
Sep 2010
Aug 2010
25 Aug · Disclosure
Board of Directors of the Company at its meeting held on November 16, 2009 have allotted 4,250 equity shares to following: 1. ....5 Aug · Results
Jul 2010
9 Jul · Updates on Open Offer
Jun 2010
Mar 2010
Feb 2010
26 Feb · Management
Board of Directors of the Company at its meeting held on February 26, 2010, have unanimously appointed the following Directors. 1. ....
Jan 2010
19 Jan · Corporate action
Annual General Meetings (AGM) for the year ended March 31, 2008 and March 31, 2009 are conducted as per the order of Hon'ble High Court ....13 Jan · Results
13 Jan · Results